Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAtyr Pharma Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.16 | -$0.12 | -$0.14 |
| Q2 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2026 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q4 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
Atyr Pharma Inc Earnings Date And Information
Atyr Pharma Inc last posted its earnings results on Thursday, November 6th, 2025. The company reported $-0.26 earnings per share for the quarter, missing analysts' consensus estimates of $-0.2 by $0.06. The company had revenue of 190.00 K for the quarter and had revenue of 235.00 K for the year. Atyr Pharma Inc has generated $-1 earnings per share over the last year ($-0.86 diluted earnings per share) and currently has a price-to-earnings ratio of -1.35. Atyr Pharma Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Atyr Pharma Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | -$0.20 | -$0.26 | -0.06 | $1.33 M | $190.00 K |
| 08/07/2025 | Q2 2025 | -$0.18 | -$0.22 | -0.04 | N/A | $0 |
| 05/07/2025 | Q1 2025 | -$0.19 | -$0.17 | 0.02 | N/A | $0 |
| 03/13/2025 | Q4 2024 | -$0.23 | -$0.18 | 0.05 | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.22 | -$0.23 | -0.01 | $21.67 K | $0 |
| 08/13/2024 | Q2 2024 | -$0.22 | -$0.23 | -0.01 | $60.00 K | $0 |
| 05/02/2024 | Q1 2024 | -$0.24 | -$0.23 | 0.01 | N/A | $235.00 K |
| 03/14/2024 | Q4 2023 | -$0.24 | -$0.25 | -0.01 | N/A | $0 |
| 11/09/2023 | Q3 2023 | N/A | -$0.20 | N/A | N/A | $353.00 K |
| 06/29/2023 | Q2 2023 | N/A | -$0.22 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.29 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.26 | N/A | N/A | $10.39 M |
| 09/28/2022 | Q3 2022 | N/A | -$0.46 | N/A | N/A | $0 |
| 06/28/2022 | Q2 2022 | N/A | -$0.44 | N/A | N/A | $0 |
| 03/29/2022 | Q1 2022 | N/A | -$0.44 | N/A | N/A | $0 |
| 12/29/2021 | Q4 2021 | N/A | -$0.31 | N/A | N/A | $0 |
| 09/28/2021 | Q3 2021 | N/A | -$0.42 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.64 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$0.51 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$0.47 | N/A | N/A | $2.05 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Atyr Pharma Inc Earnings: FAQ's
The conference call for Atyr Pharma Inc's latest earnings report can be listened to online.
The conference call transcript for Atyr Pharma Inc's latest earnings report can be read online.
Atyr Pharma Inc (:ATYR) has a recorded annual revenue of $235.00 K.
Atyr Pharma Inc (:ATYR) has a recorded net income of $-64,023,000.Atyr Pharma Inc has generated $-0.86 earnings per share over the last four quarters.
Atyr Pharma Inc (:ATYR) has a price-to-earnings ratio of -1.35 and price/earnings-to-growth ratio is 0.36.